抑制自噬增强门冬酰胺酶对小细胞肺癌细胞H1688和H446的抗癌作用

隋征; 谭群友; 王如文; 邓波; 陶绍霖; 范小青; 金花

doi:10.16016/j.1000-5404.201610012

您当前的位置：

首页 >

文章列表页 >

抑制自噬增强门冬酰胺酶对小细胞肺癌细胞H1688和H446的抗癌作用

更新时间：2026-01-09

- 抑制自噬增强门冬酰胺酶对小细胞肺癌细胞H1688和H446的抗癌作用
- Inhibition of autophagy enhances anticancer effect of asparaginase in small cell lung cancer H1688 and H446 cells
- 第三军医大学学报 2017年39卷第6期页码：515-521
- 作者机构：
  
  400042 重庆，第三军医大学大坪医院野战外科研究所胸外科
- 作者简介：
  
  [谭群友，E-mail: tanqy001@163.com Tan Qunyou, E-mail: tanqy001@163.com
- 基金信息：
  
  国家自然科学基金面上项目(81172239)
- DOI：10.16016/j.1000-5404.201610012
  中图分类号： R734.2; R966; R979.19
- 收稿：2016-10-03，
  
  修回：2016-11-03，
  
  纸质出版：2017-06
- 稿件说明：
移动端阅览
隋征, 谭群友, 王如文, 等. 抑制自噬增强门冬酰胺酶对小细胞肺癌细胞H1688和H446的抗癌作用[J]. 第三军医大学学报, 2017,39(6):515-521.

Zheng Sui, Qunyou Tan, Ruwen Wang, et al. Inhibition of autophagy enhances anticancer effect of asparaginase in small cell lung cancer H1688 and H446 cells[J]. Journal of Third Military Medical University, 2017, 39(6): 515-521.
隋征, 谭群友, 王如文, 等. 抑制自噬增强门冬酰胺酶对小细胞肺癌细胞H1688和H446的抗癌作用[J]. 第三军医大学学报, 2017,39(6):515-521. DOI： 10.16016/j.1000-5404.201610012.

Zheng Sui, Qunyou Tan, Ruwen Wang, et al. Inhibition of autophagy enhances anticancer effect of asparaginase in small cell lung cancer H1688 and H446 cells[J]. Journal of Third Military Medical University, 2017, 39(6): 515-521. DOI： 10.16016/j.1000-5404.201610012.

摘要

目的

研究门冬酰胺酶 (asparaginase，AN) 对小细胞肺癌H1688和H446细胞的抗癌作用，探讨自噬在AN抗癌过程中的功能。

方法

采用MTT法及台盼蓝染色法检测AN单独或联用自噬抑制剂氯喹 (chloroquine，CQ) 对H1688和H446细胞的生长抑制作用；免疫荧光法观察自噬标记物LC3表达，示踪自噬体形成；Western blot检测自噬相关蛋白LC3及Akt/mTOR信号通路的表达。

结果

AN呈浓度依赖性抑制H1688和H446细胞增殖并促进其死亡 (

0.05)；AN处理组可以显著增加H1688和H446细胞自噬小体数量并诱导LC3-Ⅱ表达；自噬抑制剂CQ提高AN对H1688和H446细胞杀伤作用 (

0.05)；AN作用H1688细胞后p-Akt、p-mTOR、p-70S6K蛋白表达降低。

结论

AN对小细胞肺癌H1688和H446细胞具有抑制作用并诱导细胞保护性自噬，阻断自噬可以增强AN对小细胞肺癌H1688和H446细胞的抗癌疗效。

Abstract

Objective

To study the anticancer effect of asparaginase (AN) and the role of autophagy in the anticancer process of AN in small cell lung cancer H1688 and H446 cells.

Methods

MTT assay and trypan blue exclusion assay were applied to assess the viability of H1688 and H446 cells after treatment with AN alone or in combined with autophagy inhibitor chloroquine (CQ). Then the formation of autophagy marker LC3 was observed by immunofluorescence assay. Western blotting was used to determine the expression of LC3 and Akt/mTOR signal pathway proteins.

Results

AN inhibited cell growth in a dose-dependent manner (

0.05)

and significantly increased the quantity of autophagy bodies and the expression of LC3-Ⅱ in H1688 and H446 cells. CQ promoted the inhibitory effect of AN to H1688 and H446 cells (

0.05). AN also suppressed the expression of p-Akt

p-mTOR and p-70S6K in H1688 cells.

Conclusion

AN inhibits the growth of H1688 and H446 cells

and inhibition of cytoprotective autophagy enhances the anticancer effect of AN.

关键词

Keywords

references

D'Angelo S P, Pietanza M C. The molecular pathogenesis of small cell lung cancer[J]. Cancer Biol Ther, 2010, 10(1): 1-10. DOI:10.4161/cbt.10.1.12045

Dowell J E. Small cell lung cancer: are we making progress[J]. Am J Med Sci, 2010, 339(1): 68-76. DOI:10.1097/MAJ.0b013e3181bccef5

Pieters R, Hunger S P, Boos J, et al. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase[J]. Cancer, 2011, 117(2): 238-249. DOI:10.1002/cncr.25489

Kotzia G, Lappa K, Labrou N. Tailoring structure-function properties of L-asparaginase: engineering resistance to trypsin cleavage[J]. Biochem J, 2007, 404(2): 337-343. DOI:10.1042/BJ20061708

Panosyan E H, Wang Y, Xia P, et al. Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors[J]. Mol Cancer Res, 2014, 12(5): 694-702. DOI: 10.1158/1541-7786.MCR-13-0576

Kobrinsky N L, Sposto R, Shah N R, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912[J]. J Clin Oncol, 2001, 19(9): 2390-2396. DOI:10.1200/JCO.2001.19.9.2390

Lorenzi P L, Llamas J, Gunsior M, et al. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines[J]. Mol Cancer Ther, 2008, 7(10): 3123-3128. DOI:10.1158/1535-7163.MCT-08-0589

Erdi B, Nagy P, Zvara A, et al. Loss of the starvation-induced gene Rack1 leads to glycogen deficiency and impaired autophagic responses in Drosophila[J]. Autophagy, 2012, 8(7): 1124-1135.DOI: 10.4161/auto.20069

Chen M L, Yi L, Jin X, et al. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway[J]. Autophagy, 2013, 9(12): 2033-2045.DOI: 10.4161/auto.26336

Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress[J]. Nat Med, 2007, 13(5): 619-624.DOI: 10.1038/nm1574

Shajahan-Haq A N, Cook K L, Schwartz-Roberts J L, et al. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer[J]. Mol Cancer, 2014, 13: 239. DOI: 10.1186/1476-4598-13-239

Jin Z, Zheng L, Xin X, et al. Upregulation of forkhead box O3 transcription is involved in C2-ceramide induced apoptosis and autophagy in ovarian cancer cells in vitro [J]. Mol Med Rep, 2014, 10(6): 3099-3105.DOI: 10.3892/mmr.2014.2664

Pan H, Wang Z, Jiang L, et al. Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib[J]. Sci Rep, 2014, 4: 6683. DOI: 10.1038/srep06683

Bansal S, Srivastava A, Mukherjee G, et al. Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action[J]. FASEB J, 2012, 26(3): 1161-1171. DOI: 10.1096/fj.11-191254

Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing[J]. EMBO J, 2000, 19(21): 5720-5728.DOI: 10.1093/emboj/19.21.5720

Eisenberg-Lerner A, Bialik S, Simon H U, et al. Life and death partners: apoptosis, autophagy and the cross-talk between them[J]. Cell Death Differ, 2009, 16(7): 966-975. DOI: 10.1038/cdd.2009.33

Carew J S, Kelly K R, Nawrocki S T. Autophagy as a target for cancer therapy: new developments[J]. Cancer Manag Res, 2012, 4: 357-365. DOI: 10.2147/CMAR.S26133

Kuma A, Mizushima N. Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism[J]. Semin Cell Dev Biol, 2010, 21(7): 683-690.DOI: 10.1016/j.semcdb.2010.03.002

Li X, Lu Y, Pan T, et al. Roles of autophagy in cetuximab-mediated cancer therapy against EGFR[J]. Autophagy, 2010, 6(8): 1066-1077. DOI: 10.4161/auto.6.8.13 366

Li Y, Zhu H, Zeng X, et al. Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-beta in human glioma cells[J]. Mol Neurobiol, 2013, 47(3): 1000-1010. DOI: 10.1007/s12035-013-8403-0

Sy L K, Yan S C, Lok C N, et al. Timosaponin A-Ⅲ induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells[J]. Cancer Res, 2008, 68(24): 10229-10237. DOI: 10.1158/0008-5472.CAN-08-1983

Wakuda K, Kenmotsu H, Serizawa M, et al. Molecular profiling of small cell lung cancer in a Japanese cohort[J]. Lung Cancer, 2014, 84(2): 139-144.DOI: 10.1016/j.lungcan. 2014.02.013

Wojtalla A, Fischer B, Kotelevets N, et al. Targeting the phosphoinositide 3-kinase p110-alpha isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer[J]. Clin Cancer Res, 2013, 19(1): 96-105. DOI: 10.1158/ 1078-0432.CCR-12-1138

祁迪, 谭群友, 王如文, 等.吴茱萸碱抑制PI3K/AKT通路诱导小细胞肺癌H1688和H446细胞凋亡[J].第三军医大学学报, 2016, 38(4): 330-337. DOI: 10.16016/j.1000-5404.201508031

Qi D, Tan Q Y, Wang R W, et al.Evodiamine induces apoptosis of small-cell lung cancer H1688 and H446 cells via inhibiting PI3K/AKT pathway[J]. J Third Mil Med Univ, 2016, 38(4): 330-337. DOI:10.16016/j.1000-5404.201508031

Zhang H, Guo M, Chen J H, et al. Osteopontin knockdown inhibits alphav, beta3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway[J]. Cell Physiol Biochem, 2014, 33(4): 991-1002.DOI: 10.1159/000358670

Guertin D A, Sabatini D M. Defining the role of mTOR in cancer[J]. Cancer Cell, 2007, 12(1): 9-22. DOI: 10.1016/j.ccr. 2007.05.008

Chang L, Graham P H, Hao J, et al. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways[J]. Cell Death Dis, 2014, 5: e1437. DOI: 10.1038/cddis.2014.415

Jung C H, Ro S H, Cao J, et al. mTOR regulation of autophagy[J]. FEBS Lett, 2010, 584(7): 1287-1295.DOI: 10.1016/j.febslet.2010.01.017

Lin C, Wang Z, Li L, et al. The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma[J]. Appl Microbiol Biotechnol, 2015, 99(20): 8487-8494. DOI: 10.1007/s00253-015-6565-6

Wang Z, Shi X, Li Y, et al. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells[J]. Cell Death Dis, 2014, 5:e1563. DOI: 10.1038/cddis.2014.503

Song P, Ye L, Fan J, et al. Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells[J]. Oncotarget, 2015, 6(6): 3861-3873. DOI: 10.18632/oncotarget.2869

Willems L, Jacque N, Jacquel A, et al. Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia[J]. Blood, 2013, 122(20): 3521-3532.DOI: 10.1182/blood-2013-03-493163

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

骨钙素在阿尔茨海默病细胞模型中的神经保护作用与机制研究

小细胞肺癌碱基切除修复蛋白表达和免疫细胞浸润与预后关系的研究

RANKL通过ROS介导HIF-1α下调促进自噬和破骨细胞分化

转录因子EB增强巨噬细胞自噬功能及逆转内毒素耐受的作用

自噬诱导剂亚精胺改善脑出血后脑损伤